查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1716851

临床试验设备和支援解决方案市场（按组件、阶段、治疗领域和最终用户划分）—2025-2030 年全球预测

Clinical Trial Equipment & Ancillary Solutions Market by Component, Phase, Therapeutic Area, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024年临床试验设备和辅助解决方案市值为45.8亿美元，预计2025年将成长至50亿美元，复合年增长率为8.84%，预计到2030年将达到76.2亿美元。

主要市场统计数据
基准年2024年 45.8亿美元
预计2025年 50亿美元
预测年份 2030 76.2亿美元
复合年增长率（%） 8.84%

临床试验是推动医学研究和创新的基石，临床试验设备和辅助解决方案的效率和稳健性直接影响新治疗方法发现的速度和成功。在过去的十年中，先进技术与传统方法的结合彻底改变了临床试验的进行方式。日益复杂的法规、对数据准确性的不断提高的期望以及对临床开发速度的追求都在帮助塑造当前的市场环境。

在这个快速发展的领域，产业相关人员正在寻求解决方案，不仅要确保遵守不断变化的法规，还要透过简化流程和增强资料管理能力来提高业务效率。对准确、可靠和经济高效的工具的追求开启了一个以数位转型和对专业临床试验设备日益增长的需求为标誌的创新新时代。主要决策者现在准备考虑一系列互补的解决方案，支援从数据收集和管理到患者参与和供应链物流的一切。这全面的概述对市场区隔、区域趋势和竞争动态进行了深入分析，为产业领导者提供了当前和未来商业机会的清晰图景。

科技与医疗保健的融合继续推动根本性的改进，创造了一个需要最新设备与先进数位解决方案整合的环境。相关人员可以深入了解不仅影响市场趋势而且为这一重要产业领域的策略创新和投资铺路的关键因素。

重塑临床试验设备格局的变革

在技​​术创新和不断变化的市场需求的推动下，临床试验设备和辅助解决方案的运作模式发生了重大变革时期并被重新定义。新的数位平台简化了从电子资料撷取到先进的影像处理和监控系统的每个流程，大大缩短了时间并最大限度地减少了人为错误。对数据完整性的重视，加上集中化验服务和先进的临床试验管理系统日益增长的重要性，正在为更灵活、敏捷的临床研究环境铺平道路。

此外，从传统的纸本记录到整合的云端基础的系统的演变不仅提高了业务效率，而且从根本上改变了相关人员参与的动态。增强的连接性和数据分析能力使决策者能够更积极地管理风险并确保合规性。朝向更自动化、可互通的系统迈进凸显了产业朝向卓越营运的更广泛趋势，其中技术创新是实现准确和快速临床结果的催化剂。随着这一趋势的加速，临床试验部门将受益于效率的提高、患者治疗效果的改善，并最终更快地将突破性治疗方法推向市场。

市场区隔分析的关键见解

对市场细分的深入研究揭示了一个强大的框架，使相关人员能够了解影响临床试验设备和辅助解决方案格局的各种因素。分析按组件分为两类，并对辅助解决方案和设备市场进行全面评估。辅助解决方案包含广泛的专业服务，包括中央实验室服务、临床试验管理系统、数据管理和分析、电子数据采集系统、互动式回应技术、患者参与解决方案以及供应链和物流解决方案。同时，设备部门专注于符合严格临床标准的配药和包装设备、诊断影像、测试和监测设备。

除了基于组件的细分之外，市场还根据临床试验阶段进行细分，从第一阶段到第四阶段。这种细分确保了针对特定需求量身定制的解决方案，例如早期安全评估、剂量优化、功效确定和上市后监测。此外，心臟病学、免疫学、感染疾病、神经病学和肿瘤学等治疗领域增加了进一步的特殊性，因为它们允许公司解决与每个领域相关的独特挑战。

该分析也扩展到最终用户的观点，评估学术研究机构、生技公司、受託研究机构、医疗设备公司和製药公司的市场采用。这种全面的细分使我们能够细緻地了解客户需求和市场动态，为在快速变化的临床试验环境中优化资源配置和最大化投资收益铺平了道路。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球临床试验的兴起
      • 个人化医疗和标靶治疗的兴起
      • 临床研发投入快速增加
    • 限制因素
      • 营运成本高且预算分配有限
    • 机会
      • 持续投资模组化或可携式测试设备，用于各种临床试验设置
      • 加强与远端医疗提供者的合作，实现与测试设备的无缝集成
    • 任务
      • 临床试验流程数位化引发资料隐私担忧
  • 市场区隔分析
    • 建构模组：扩大临床试验仪器的应用，确保准确性与病人安全
    • 治疗领域：扩大临床试验设备和辅助解决方案在肿瘤学的应用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章临床试验设备和支援解决方案市场（按组件）

  • 互补解决方案
    • 中央化验服务
    • 临床试验管理系统（CTMS）
    • 资料管理和分析服务
    • 电子资料撷取（EDC）系统
    • 互动式回应技术（IRT）
    • 病人参与解决方案
    • 供应链和物流解决方案
  • 装置
    • 药品分配/包装设备
    • 影像设备
    • 实验室设备
    • 监控设备

第七章临床试验设备和支援解决方案市场（按阶段）

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第八章临床试验设备和支援解决方案市场（按治疗领域）

  • 心臟病学
  • 免疫学
  • 感染疾病
  • 神经病学
  • 肿瘤学

第九章临床试验设备和支援解决方案市场（按最终用户）

  • 学术研究所
  • 生技公司
  • 合约研究组织（CRO）
  • 医疗设备公司
  • 製药公司

第 10 章：美洲临床试验设备与辅助解决方案市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第 11 章亚太临床试验设备与支援解决方案市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第 12 章欧洲、中东和非洲临床试验设备及支援解决方案市场

  • 丹麦
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Axelerist
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Dassault Systemes SE
  • Emsere BV
  • Eppendorf SE
  • Eurofins Scientific SE
  • Global Vision Technologies, Inc.
  • Hitachi, Ltd.
  • IQVIA Holdings Inc.
  • Lonza Group Ltd.
  • MedNet Solutions, Inc.
  • Myonex, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Quanticate International Limited
  • Quipment SAS
  • Royal Philips
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service, Inc.
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • Zifo Technologies Private Limited
Product Code: MRR-8C74ADFC1246

The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 4.58 billion in 2024 and is projected to grow to USD 5.00 billion in 2025, with a CAGR of 8.84%, reaching USD 7.62 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 4.58 billion
Estimated Year [2025] USD 5.00 billion
Forecast Year [2030] USD 7.62 billion
CAGR (%) 8.84%

Clinical trials have become a cornerstone in advancing medical research and innovation, where the efficiency and robustness of clinical trial equipment and ancillary solutions directly influence the pace and success of new therapeutic discoveries. Over the past decade, the integration of advanced technologies with traditional methods has transformed the way clinical trials are conducted. Increasing regulatory complexities, heightened expectations for data accuracy, and the pursuit of speed in clinical development have all played a role in shaping the current market environment.

In this rapidly evolving space, industry stakeholders are seeking solutions that not only ensure compliance with evolving regulations but also improve operational efficiencies through streamlined processes and enhanced data management capabilities. The quest for precise, reliable, and cost-effective tools has ushered in a new era of innovation characterized by digital transformation and an ever-growing demand for specialized clinical trial equipment. Key decision-makers are now poised to explore a range of ancillary solutions that support everything from data capture and management to patient engagement and supply chain logistics. This comprehensive overview sets the stage for a detailed analysis of market segmentation, regional trends, and competitive dynamics, offering industry leaders a clear window into current and future opportunities.

The convergence of technology and healthcare continues to drive radical improvements, fostering an environment where the integration of modern equipment and advanced digital solutions is critical. Stakeholders can expect a deep dive into the key factors that not only influence market trends but also open avenues for strategic innovation and investment in this crucial industry segment.

Transformative Shifts Reshaping the Clinical Trial Equipment Landscape

Significant transformative shifts have redefined the operational paradigms within clinical trial equipment and ancillary solutions, driven largely by innovations in technology and evolving market demands. Emerging digital platforms have streamlined processes across the board, from electronic data capture to advanced imaging and monitoring systems, drastically reducing timelines and minimizing human error. The emphasis on data integrity, coupled with the rising importance of centralized lab services and sophisticated clinical trial management systems, is paving the way for a more agile and responsive clinical research environment.

Moreover, the evolution from traditional paper-based records to integrated, cloud-based systems has not only increased operational efficiency but has also radically altered the dynamics of stakeholder engagement. Enhanced connectivity and data analytics capabilities have empowered decision-makers to take a more proactive role in managing risks and ensuring compliance. The industry's shift towards more automated and interoperable systems underscores a broader trend towards operational excellence, where technological innovation is the catalyst for precise and rapid clinical outcomes. As these trends accelerate, the clinical trial sector is positioned to benefit from increased efficiencies, improved patient outcomes, and ultimately a faster path to market for groundbreaking therapies.

Key Insights from Market Segmentation Analysis

A deep dive into market segmentation reveals a robust framework that enables stakeholders to understand the diverse elements shaping the clinical trial equipment and ancillary solutions landscape. The analysis is bifurcated by components; the market is thoroughly evaluated across ancillary solutions and equipment. Ancillary solutions incorporate a wide range of specialized services such as central lab services, clinical trial management systems, data management and analytics, electronic data capture systems, interactive response technology, patient engagement solutions, and supply chain and logistics solutions. In contrast, equipment studies focus on drug dispensing and packaging devices, imaging equipment, laboratory instruments, and monitoring devices designed to meet stringent clinical standards.

In addition to the component-based segmentation, the market is segmented by the phase of clinical trials, covering Phase I through Phase IV. This granularity ensures that solutions are tailored to the specific needs of early safety assessments, dosage optimization, efficacy determination, and post-market surveillance. Furthermore, therapeutic areas including cardiology, immunology, infectious diseases, neurology, and oncology add another layer of specificity, permitting companies to address the unique challenges associated with each field.

The analysis also extends to the end-user perspective, evaluating the market's adoption across academic and research institutions, biotechnology firms, contract research organizations, medical device companies, and pharmaceutical companies. This comprehensive segmentation allows for a nuanced understanding of customer needs and market dynamics, paving the way for targeted strategic initiatives that optimize resource allocation and maximize return on investment in a rapidly shifting clinical trials environment.

Based on Component, market is studied across Ancillary Solutions and Equipments. The Ancillary Solutions is further studied across Central Lab Services, Clinical Trial Management Systems (CTMS), Data Management & Analytics Services, Electronic Data Capture (EDC) Systems, Interactive Response Technology (IRT), Patient Engagement Solutions, and Supply Chain & Logistics Solutions. The Equipments is further studied across Drug Dispensing/Packaging Devices, Imaging Equipment, Laboratory Instruments, and Monitoring Device.

Based on Phase, market is studied across Phase I, Phase II, Phase III, and Phase IV.

Based on Therapeutic Area, market is studied across Cardiology, Immunology, Infectious Diseases, Neurology, and Oncology.

Based on End-User, market is studied across Academic/Research Institutions, Biotechnology Firms, Contract Research Organizations (CROs), Medical Device Companies, and Pharmaceutical Companies.

Regional Trends and Insights in Clinical Innovation

The regional analysis of the clinical trial equipment and ancillary solutions market provides a global perspective on the forces shaping industry innovations. In the Americas, robust investments and a mature infrastructure continue to drive advancements, with strong emphasis on regulatory compliance and the adoption of cutting-edge technology solutions. This region effectively balances traditional research methodologies with modern digital technologies, creating an ecosystem that is both resilient and dynamic.

The landscape in Europe, the Middle East, and Africa is characterized by a blend of regulatory diversity and a growing appetite for innovation. The varied regulatory environments combined with significant investments have spurred the adoption of advanced ancillary solutions and equipment designed to meet localized compliance needs. This area benefits from established research institutions and a strong collaborative network that is increasingly turning to digital transformation as a means to address complex challenges.

Meanwhile, the Asia-Pacific region is emerging as a hotbed of innovation, fueled by rapid urbanization, accelerating healthcare reforms, and a rising focus on research and development. Market players in this region are aggressively investing in state-of-the-art laboratories, data-driven insights, and novel ancillary solutions that cater to the needs of a diverse patient population. Together, these regions form a mosaic of growth opportunities, each contributing uniquely to the global evolution of clinical trial technologies and practices.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, United Arab Emirates, and United Kingdom.

Competitive Dynamics and Company-Level Insights

An in-depth analysis of key companies operating in the clinical trial equipment and ancillary solutions market provides a comprehensive understanding of competitive dynamics and investment potential. The market features a diverse array of prominent players including Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, and Bio-Rad Laboratories, Inc. Leading the pack are companies like Charles River Laboratories International, Inc. and Dassault Systemes SE, whose innovative approaches and robust technology platforms set industry benchmarks.

Other influential firms such as Emsere B.V., Eppendorf SE, and Eurofins Scientific SE are further driving the evolution of ancillary services, catering to specialized needs in clinical trial management and data analytics. In parallel, Global Vision Technologies, Inc., Hitachi, Ltd., and IQVIA Holdings Inc. continue to spearhead technological advancements, ensuring that clinical trials are conducted with precision and reliability. Companies like Lonza Group Ltd. and MedNet Solutions, Inc. are instrumental in the development of specialized equipment, aligning their product portfolios with the evolving demands of clinical research.

Industry stalwarts such as Myonex, Inc., Navitas Inc., and Oracle Corporation have harnessed the power of digital transformation to deliver solutions that enhance operational efficiency and data accuracy. Additionally, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, and Thermo Fisher Scientific, Inc. play a crucial role in shaping market trends and setting higher standards for both ancillary solutions and clinical trial equipment. The market is further enriched by the contributions of United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited, all of which are instrumental in redefining how clinical research is conducted on a global scale.

The report delves into recent significant developments in the Clinical Trial Equipment & Ancillary Solutions Market, highlighting leading vendors and their innovative profiles. These include Almac Group Limited, Ancillare, LP, Avantor, Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories, Inc., Charles River Laboratories International, Inc., Dassault Systemes SE, Emsere B.V., Eppendorf SE, Eurofins Scientific SE, Global Vision Technologies, Inc., Hitachi, Ltd., IQVIA Holdings Inc., Lonza Group Ltd., MedNet Solutions, Inc., Myonex, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Quanticate International Limited, Quipment SAS, Royal Philips, Thermo Fisher Scientific, Inc., United Parcel Service, Inc., Veeva Systems Inc., Yokogawa Electric Corporation, and Zifo Technologies Private Limited. Actionable Recommendations for Driving Strategic Growth

Industry leaders are positioned to capitalize on emerging trends and set the stage for long-term growth by embracing integrated strategies that enhance both operational efficiency and technological adoption. It is essential to leverage data analytics and cloud-based solutions to streamline clinical trial management, ensuring that every phase from design to post-market surveillance is executed with precision and speed.

Stakeholders should focus on strategic investments in advanced equipment and ancillary solutions that are adaptable to evolving regulatory frameworks and patient-centric approaches. Strengthening collaborations between research institutions, technology providers, and regulatory bodies can further foster an environment of innovation, ensuring that new entrants and established players alike have access to best practices and the latest market insights. Embracing a forward-looking perspective will enable industry leaders to meet the increasing demands of clinical trials while reducing risks and accelerating time-to-market for groundbreaking therapies.

Concluding Perspectives on Market Transformation and Future Opportunities

In conclusion, the clinical trial equipment and ancillary solutions market is undergoing a period of profound transformation. Anchored by innovative technological advancements, rigorous regulatory standards, and a clear demand for operational excellence, the industry is poised to deliver significant improvements in clinical outcomes and patient engagement. The comprehensive segmentation framework, ranging from component and phase to therapeutic area and end-user, highlights the diverse challenges and opportunities that industry stakeholders must navigate.

The evolving regional dynamics and the robust competition among leading companies underscore the imperative for strategic agility and digital integration. As the market continues to advance, organizations that proactively adopt new technologies and refine their operational frameworks will not only stay ahead of the competition but also contribute to the acceleration of clinical innovation. The insights provided in this analysis serve as a critical roadmap for decision-makers, ensuring that they remain well-informed and strategically positioned to harness the full potential of market opportunities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising global volume of clinical trials
      • 5.1.1.2. Expansion of personalized medicine and targeted therapies
      • 5.1.1.3. Surge in investments in clinical research and development
    • 5.1.2. Restraints
      • 5.1.2.1. High operational costs and limited budget allocations
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing investments in modular or portable trial equipment for diverse clinical trial setups
      • 5.1.3.2. Increasing collaboration with telemedicine providers for seamless integration with trial equipment
    • 5.1.4. Challenges
      • 5.1.4.1. Data privacy concerns associated with digitization of clinical trial processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing adoption of clinical trial equipment for accuracy and patient safety
    • 5.2.2. Therapeutic Area: Expanding usage of clinical trial equipment and ancillary solutions in oncology
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Clinical Trial Equipment & Ancillary Solutions Market, by Component

  • 6.1. Introduction
  • 6.2. Ancillary Solutions
    • 6.2.1. Central Lab Services
    • 6.2.2. Clinical Trial Management Systems (CTMS)
    • 6.2.3. Data Management & Analytics Services
    • 6.2.4. Electronic Data Capture (EDC) Systems
    • 6.2.5. Interactive Response Technology (IRT)
    • 6.2.6. Patient Engagement Solutions
    • 6.2.7. Supply Chain & Logistics Solutions
  • 6.3. Equipments
    • 6.3.1. Drug Dispensing/Packaging Devices
    • 6.3.2. Imaging Equipment
    • 6.3.3. Laboratory Instruments
    • 6.3.4. Monitoring Device

7. Clinical Trial Equipment & Ancillary Solutions Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Immunology
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Clinical Trial Equipment & Ancillary Solutions Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic/Research Institutions
  • 9.3. Biotechnology Firms
  • 9.4. Contract Research Organizations (CROs)
  • 9.5. Medical Device Companies
  • 9.6. Pharmaceutical Companies

10. Americas Clinical Trial Equipment & Ancillary Solutions Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Finland
  • 12.4. France
  • 12.5. Germany
  • 12.6. Israel
  • 12.7. Italy
  • 12.8. Netherlands
  • 12.9. Norway
  • 12.10. Poland
  • 12.11. Qatar
  • 12.12. Russia
  • 12.13. Saudi Arabia
  • 12.14. South Africa
  • 12.15. Spain
  • 12.16. Sweden
  • 12.17. Switzerland
  • 12.18. United Arab Emirates
  • 12.19. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. FPNV Positioning Matrix, 2024
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Ancillare enhances cold chain management services for clinical trial supplies
    • 13.3.2. PRONAV Clinical strategically expanded its U.S. footprint by joining FITCI's entrepreneurial ecosystem
    • 13.3.3. Myonex strategically acquired CREAPHARM's pharmaceutical services business,
    • 13.3.4. RQM+ Acquires Libra Medical
    • 13.3.5. Lambda Therapeutics partners with Medidata to automate and streamline data management processes for greater clinical trial efficiency
    • 13.3.6. Mednet Launches DICOM Imaging Capabilities Within the iMednet eClinical Platform
    • 13.3.7. Launch Therapeutics Selects Medidata AI Intelligent Trials to Accelerate Clinical Trial Development
    • 13.3.8. Clinical ink Announces Strategic Partnership with Mural Health for New Patient Payment and Logistics Capabilities
    • 13.3.9. Cloudbyz Unveils Groundbreaking Electronic Data Capture Solution to Streamline Clinical Research and Accelerate Launch of New Therapies
    • 13.3.10. Clario Launches Cloud-Based Image Viewer for Clinical Trials
    • 13.3.11. ClinChoice continues expansion with CRO acquisition
    • 13.3.12. Suvoda launches purpose-built software platform
    • 13.3.13. Huma acquires Alcedis to expand clinical trial platform
    • 13.3.14. CardieX Subsidiary ATCOR Partners with Invaryant to Enable Clinical Trials with Advanced New AI Medical Technology
    • 13.3.15. RQM+ Launches Clinical Trial Services
    • 13.3.16. Edison Partners leads USD 21 million funding round for clinical trial intelligence disruptor Lokavant
    • 13.3.17. Parexel Opens Clinical Trial Supplies and Logistics Depot in Suzhou, China
    • 13.3.18. Philips launches 12-lead ECG solution for decentralized clinical trials
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Almac Group Limited
  • 2. Ancillare, LP
  • 3. Avantor, Inc.
  • 4. Axelerist
  • 5. B. Braun SE
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Dassault Systemes SE
  • 9. Emsere B.V.
  • 10. Eppendorf SE
  • 11. Eurofins Scientific SE
  • 12. Global Vision Technologies, Inc.
  • 13. Hitachi, Ltd.
  • 14. IQVIA Holdings Inc.
  • 15. Lonza Group Ltd.
  • 16. MedNet Solutions, Inc.
  • 17. Myonex, Inc.
  • 18. Navitas Inc.
  • 19. Oracle Corporation
  • 20. Parexel International Corporation
  • 21. Quanticate International Limited
  • 22. Quipment SAS
  • 23. Royal Philips
  • 24. Thermo Fisher Scientific, Inc.
  • 25. United Parcel Service, Inc.
  • 26. Veeva Systems Inc.
  • 27. Yokogawa Electric Corporation
  • 28. Zifo Technologies Private Limited

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-CURRENCY
  • FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-LANGUAGE
  • FIGURE 3. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
  • FIGURE 4. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 17. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 25. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET DYNAMICS
  • TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 116. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 122. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 128. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 129. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 130. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 136. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 140. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 141. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 142. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 146. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 147. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 148. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 149. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 150. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 152. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 153. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 154. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 155. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 166. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 167. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 168. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 169. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 207. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 208. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 212. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 213. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 214. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 220. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 225. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 226. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 231. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 232. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 243. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 244. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 248. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 249. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 250. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 254. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 255. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 256. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 261. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 262. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 263. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 264. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 265. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 266. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 267. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
  • TABLE 268. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED KINGDOM CLINICAL TRIAL EQUIPM